Clinical Trial

Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision

Completed
View on ClinicalTrials.gov →
Summary
This clinical trial evaluates the safety and efficacy of High Purity Type I Collagen scaffold for breast volume restoration following breast-conserving surgery (BCS). The regenerative collagen matrix serves as a biocompatible scaffold promoting tissue ingrowth, neovascularization, and gradual remodeling, thereby improving cosmetic outcomes and patient quality of life after partial mastectomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-18.
Status change: Recruiting → Completed 2026-03-25
Trial Details
NCT Number NCT07219316
Lead Sponsor Adichunchanagiri Institute of Medical Sciences, B G Nagara
Conditions Breast-Conserving Surgery
Enrollment 40 participants
Start Date 2025-10-15
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-25 (estimated)
Updated on ClinicalTrials.gov 2026-03-27